Nextgen Biomed Ltd

Tel Aviv Stock Exchange NXGN.TA

Nextgen Biomed Ltd Free Cash Flow for the year ending December 31, 2023: USD -1.22 M

Nextgen Biomed Ltd Free Cash Flow is USD -1.22 M for the year ending December 31, 2023, a -56.24% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Nextgen Biomed Ltd Free Cash Flow for the year ending December 31, 2022 was USD -782.32 K, a 23.02% change year over year.
  • Nextgen Biomed Ltd Free Cash Flow for the year ending December 31, 2021 was USD -1.02 M, a -110.95% change year over year.
  • Nextgen Biomed Ltd Free Cash Flow for the year ending December 31, 2020 was USD -481.77 K.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
Tel Aviv Stock Exchange: NXGN.TA

Nextgen Biomed Ltd

CEO Mr. Harel Hershtik
IPO Date Aug. 12, 2002
Location Israel
Headquarters 132 Azrieli Towers Round Building
Employees 5
Sector Health Care
Industries
Description

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email